- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0131688

Korus Pharma Private Limited
About Korus Pharma Private Limited
Data last updated:
Korus Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the electronics manufacturing segment of the consumer electronics and durables sector. It was incorporated on 06 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24299TN2021PTC144562. Its GSTIN is 33AAICK8736E1ZG (Tamil Nadu).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Manakchand Deepika and Balchand Trishla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.19 Marshall Road Egmore, Chennai, Tamil Nadu, India – 600008.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.89 Lakh, a decline of 93% compared to the previous year. For the same year it recorded a net profit of ₹5,789 (net margin 1.5%) and EBITDA of ₹35,136 (EBITDA margin 9%).
Korus Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0131688).
Company details
Recognitions & Rankings of Korus Pharma
Contact details
Korus Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.19 Marshall Road Egmore, Chennai, Tamil Nadu, India – 600008
- IndustryConsumer Electronics & Durables, Electronics Manufacturing
To see the full contact details of Korus Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Korus Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Korus Pharma Private Limited, buy the company report.
Financials of Korus Pharma Private Limited
FY 2025 filings availableKorus Pharma Private Limited reported revenue of ₹3.89 Lakh (down 93% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 93% in the latest year. EBITDA fell 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹35,136 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹5,789 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 9% | |||
| Net Profit Margin | 1.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Korus Pharma Private Limited, buy the company report.
Board of directors of Korus Pharma Private Limited
Korus Pharma has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manakchand Deepika | Director | 06 Jul 2021 | 5 Years 3 Months | Current |
| Balchand Trishla | Director | 06 Jul 2021 | 5 Years 3 Months | Current |
| Ramesh Jain Also directs: Scope Specialities LLP, Deepak Cellulose Private Limited, Reckon Organics Private Limited and 1 more | Director | 05 Jan 2026 | 0 Years 9 Months | Current |
| Ashish Jain Also directs: Scope Specialities LLP, Deepak Cellulose Private Limited, Reckon Organics Private Limited and 3 more | Director | 05 Jan 2026 | 0 Years 9 Months | Current |
| Sachinkumar Vijaylal Jain Also directs: Scope Specialities LLP, Deepak Cellulose Private Limited, Reckon Organics Private Limited and 5 more | Director | 05 Jan 2026 | 0 Years 9 Months | Current |
Auditor
Korus Pharma Private Limited is audited by POONAM ANKIT & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| POONAM ANKIT & ASSOCIATES | FY 2022 | 017409S |
Shareholding
The shareholding of Korus Pharma Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Korus Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Korus Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Korus Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Korus Pharma Private Limited has 1 active EPFO establishment as of Mar 25, 2024.
GST
Korus Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAICK8736E1ZG | Tamil Nadu | Active | 28 Aug 2021 |
To see the full GST registrations and return filing status of Korus Pharma Private Limited, buy the company report.
Recent activity
Korus Pharma Private Limited has 5 board changes on record since 2021: 5 appointments. The latest: Ashish Jain was appointed as Director on 05 Jan 2026.
Frequently asked questions
Korus Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in electronics manufacturing, within the consumer electronics and durables industry. It was incorporated on 06 July 2021 (5+ years old) and is registered under CIN U24299TN2021PTC144562.
Korus Pharma has 5 current directors:
- Manakchand Deepika - Director
- Balchand Trishla - Director
- Ramesh Jain - Director
- Ashish Jain - Director
- Sachinkumar Vijaylal Jain - Director
The latest financial statements of Korus Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Korus Pharma is 33AAICK8736E1ZG, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Korus Pharma is U24299TN2021PTC144562. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Korus Pharma was incorporated on 06 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
Ashish Jain was appointed as Director on 05 Jan 2026. Ramesh Jain was appointed as Director on 05 Jan 2026. Sachinkumar Vijaylal Jain was appointed as Director on 05 Jan 2026. Korus Pharma has 5 board changes on record in total.
Yes, Korus Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0131688).
The registered office of Korus Pharma is at No.19 Marshall Road Egmore, Chennai, Tamil Nadu, India – 600008.
Korus Pharma operates in the consumer electronics and durables industry, in the electronics manufacturing segment.

